Mindre end 1% af det dosisrelaterede materiale udskilles med urinen, og nedsat nyrefunktion forventes derfor ikke at påvirke fluticasonfuroats farmakokinetik.
Less than 1% of dose-related material is excreted in urine and therefore renal impairment would not be expected to affect the pharmacokinetics of fluticasone furoate.